Cargando…

Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran

BACKGROUND: Hepatitis B infection is still the main cause of chronic liver disease in Iran, which is associated with significant economic and social costs. OBJECTIVES: This study aimed to estimate the financial burden caused by CHB infection and its complications in Iran. PATIENTS AND METHODS: Preva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keshavarz, Khosro, Kebriaeezadeh, Abbas, Alavian, Seyed Moayed, Akbari Sari, Ali, Abedin Dorkoosh, Farid, Keshvari, Maryam, Malekhosseini, Seyed Ali, Nikeghbalian, Saman, Nikfar, Shekoufeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427913/ https://www.ncbi.nlm.nih.gov/pubmed/25977694 http://dx.doi.org/10.5812/hepatmon.15(4)2015.25854

Ejemplares similares

A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model
por: Keshavarz, Khosro, et al.
Publicado: (2016)

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

The Economic Burden of Liver Cirrhosis in Iran: a Cost of Illness Study
por: AKBARI SARI, Ali, et al.
Publicado: (2015)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

Alveolar Echinococcosis of the Liver: Report of Three Cases From Different Geographic Areas of Iran
por: Geramizadeh, Bita, et al.
Publicado: (2012)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran
por: Aajami, Zahra, et al.
Publicado: (2019)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
por: Keshavarz, Khosro, et al.
Publicado: (2013)

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
por: Teimouri, Fatemeh, et al.
Publicado: (2017)

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted Livers: A Single-Center Study in the South of Iran
por: Geramizadeh, Bita, et al.
Publicado: (2015)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
por: Rezvanfar, Mohammad Ali, et al.
Publicado: (2013)

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus
por: Farshchi, Amir, et al.
Publicado: (2014)

Isolated Tuberculosis of Transplanted Liver, A Case Report and Review of the Literature
por: Geramizadeh, Bita, et al.
Publicado: (2013)

A Single Center Study Comparing the Stainable Iron Depositions in 1000 Explanted Cirrhotic Livers of Different Causes
por: Geramizadeh, Bita, et al.
Publicado: (2015)

An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
por: Annabi, Majid, et al.
Publicado: (2017)

A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines
por: Zartab, Saman, et al.
Publicado: (2021)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
por: Nassiri-Koopaei, Nasser, et al.
Publicado: (2014)

The Economic Burden of Breast Cancer in Iran
por: DAROUDI, Rajabali, et al.
Publicado: (2015)

Estimating the Economic Burden of Lung Cancer in Iran
por: Rezaei, Satar, et al.
Publicado: (2016)

Hepatocyte Isolation From Unused/Rejected Livers for Transplantation: Initial Step Toward Hepatocyte Transplantation, the First Experience From Iran
por: Hossein Aghdaie, Mahdokht, et al.
Publicado: (2013)

Economic burden of multiple sclerosis: a cross-sectional study in Iran
por: Rezaee, Mehdi, et al.
Publicado: (2022)

Hepatocellular Carcinoma in Two Patients with Autoimmune Hepatitis, A Single Center Experience and Review of the Literature
por: Geramizadeh, Bita, et al.
Publicado: (2013)

A comparative study of the classic and piggyback techniques for orthotopic liver transplantation
por: Nikeghbalian, Saman, et al.
Publicado: (2014)

Economic burden of breast cancer: a case of Southern Iran
por: Jalali, Faride Sadat, et al.
Publicado: (2023)

Factors affecting the economic burden of breast cancer in southern Iran
por: Jalali, Faride Sadat, et al.
Publicado: (2023)

How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?
por: Keshvari, Maryam, et al.
Publicado: (2014)

What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients?
por: Keshvari, Maryam, et al.
Publicado: (2014)

Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
por: Sharafi, Heidar, et al.
Publicado: (2015)

Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
por: Keshvari, Maryam, et al.
Publicado: (2015)

Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country
por: Ayati, Nayyereh, et al.
Publicado: (2021)

On the Occasion of the World Hepatitis Day: World Hepatitis Day and Our Achievements and Responsibilities in Iran
por: Alavian, Seyed Moayed
Publicado: (2012)

Economic Burden of Thalassemia Major in Iran, 2015
por: Esmaeilzadeh, Firooz, et al.
Publicado: (2016)

Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran
por: Samimi-Rad, Katayoun, et al.
Publicado: (2016)

The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C
por: Pouryasin, Mohammad, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_knvh0vvk1skcs18mln45715rp6